Objective: To perform an extensive analysis of the immune status of asymptomatic children with the 22q11.2 deletion syndrome, with special emphasis on the regulatory T cells (Treg) population.

Study Design: Analysis of thymic function, frequency and absolute counts of immune subsets, and phenotype of Treg were performed in 10 asymptomatic children bearing the 22q11.2 deletion and compared with 12 age-matched, healthy children.

Results: Children with 22q11.2 deletion syndrome showed a curtailed thymic output, lower T-cell levels, and a homeostatic deregulation in the CD4 T-cell compartment, characterized by a greater proliferative history in the naïve CD4 T-cell subset. Treg numbers were markedly reduced in children with 22q11.2 deletion syndrome, and remaining Treg showed mostly an activated phenotype.

Conclusions: Reduced thymic output in children with 22q11.2 deletion syndrome could be related with an increased proliferation in the naïve CD4 T-cell compartment and the consequent Treg activation to ensure that T-cell expansion remains under control. Deregulated peripheral homeostasis and loss of suppressive capacity by Treg could compromise the integrity of T-cell immunity during adulthood and play a relevant role in the increased incidence of autoimmune diseases reported in patients with the 22q11.2 deletion syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2013.12.013DOI Listing

Publication Analysis

Top Keywords

22q112 deletion
28
deletion syndrome
24
children 22q112
20
thymic output
12
cd4 t-cell
12
peripheral homeostasis
8
asymptomatic children
8
t-cell compartment
8
naïve cd4
8
22q112
7

Similar Publications

Article Synopsis
  • * Researchers evaluated AR dimensions in 74 patients, finding that 32.4% exhibited ARD, with a notable correlation between ARD severity and skeletal/connective tissue disorders.
  • * The study concluded that isolated ARD is prevalent in this population, and regular cardiac monitoring is essential for improving long-term health outcomes, despite unclear risk factors and complications.
View Article and Find Full Text PDF

Case Report: Autoimmune Psychosis in Chromosome 22q11.2 Deletion Syndrome.

Front Immunol

December 2021

Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.

Chromosome 22q11.2 deletion syndrome (22q11DS) is characterized by congenital cardiac abnormalities, hypoplastic thymus, palatal abnormalities, and hypocalcemia, although other clinical features are frequent such as autoimmune and psychiatric disorders. One-third of the patients have psychotic disorders, frequently followed by developmental regression and long-term cognitive disturbances.

View Article and Find Full Text PDF

Case Report: Ménière's Disease-Like Symptoms in 22q11.2 Deletion Syndrome.

Front Neurol

June 2021

Department of Neurology, Pusan National University School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea.

Article Synopsis
  • The 22q11.2 deletion syndrome (22q11.2DS) is a genetic disorder linked to various health issues, including heart defects, developmental delays, and hearing impairments due to ear malformations.
  • A case study describes a 38-year-old male with 22q11.2DS who experienced fluctuating hearing loss and vertigo similar to Ménière's disease over a decade.
  • Medical tests revealed issues like abnormal ear structures and endolymphatic hydrops, suggesting that problems with fluid flow in the ear can lead to acute vertigo and hearing loss in individuals with 22q11.2DS.
View Article and Find Full Text PDF

The paper presents a clinical case of congenital cleft palate as a manifestation of 22q11.2 deletion syndrome accompanied by other systemic disorders having direct impact on functional indicators and perioperative period during cleft surgery. Specific for 22q11.

View Article and Find Full Text PDF

Comparing the broad socio-cognitive profile of youth with Williams syndrome and 22q11.2 deletion syndrome.

J Intellect Disabil Res

December 2017

The Behavioral Neurogenetics Center, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.

Background: Numerous studies have assessed the socio-cognitive profile in Williams syndrome (WS) and, independently, in 22q11.2 deletion syndrome (22q11.2DS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!